Scotoma Awareness Training for Low Vision
(SPOT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Scotoma Awareness Training for Low Vision?
Research shows that training can help people with central vision loss use other parts of their eyes more effectively for tasks like reading and visual search. Studies found that with training, individuals improved their ability to focus on words and objects, and these skills were retained over time, suggesting that similar training could be beneficial for those with low vision.12345
Is Scotoma Awareness Training safe for humans?
How is Scotoma Perimetry Oculomotor Training different from other treatments for low vision?
Scotoma Perimetry Oculomotor Training is unique because it focuses on training the eyes to use a different part of the retina for vision, called a preferred retinal locus (PRL), to improve reading and visual tasks despite central vision loss. This approach is different from other treatments as it involves oculomotor training (eye movement training) to establish a new, more effective retinal location for vision, rather than relying on medication or surgery.1231011
What is the purpose of this trial?
This trial tests a new training method for older adults with Macular Degeneration, a condition causing central vision loss. The training uses a simulated blind spot to help patients become aware of their vision loss and develop new ways to see better. By making patients aware of their blind spot, the training aims to improve their vision and daily functioning. Eccentric viewing training has been shown to improve near visual acuity, reading speed, and daily functioning in people with central vision loss.
Eligibility Criteria
This trial is for adults with severe vision impairment (20/100 or worse) due to Macular Degeneration. Participants must have had this level of vision loss for at least two years and show specific light sensitivity differences between their macula and peripheral retina. Those who can't remain still during eye tracking or have very large retinal blind spots are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo 'scotoma awareness' training with a simulated scotoma to promote PRL development
Follow-up
Participants are monitored for changes in visual abilities and oculomotor strategies after training
Treatment Details
Interventions
- Control Training
- Scotoma Perimetry Oculomotor Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of California, Riverside
Collaborator